SCRI - HCA Midwest Division — Kansas City, Kansas

SCRI - HCA Midwest Division is a clinical research site located in Kansas City, Kansas, United States 61432.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

SCRI - HCA Midwest Division has participated in 1 clinical trials.

Therapeutic areas: Cancer of the Breast, Breast Cancer, Advanced Breast Cancer.

Sponsors: Innocrin Pharmaceutical.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI - HCA Midwest Division?

SCRI - HCA Midwest Division has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI - HCA Midwest Division conducted?

SCRI - HCA Midwest Division has 1 clinical trials on record. Their work covers Cancer of the Breast, Breast Cancer, Advanced Breast Cancer.

Is SCRI - HCA Midwest Division accredited by Crixeo Health?

SCRI - HCA Midwest Division has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SCRI - HCA Midwest Division?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.